Infosys CIP: Data Driven Insights for Life Science Commercial Operations - Seguridad Mania.com - España y América Latina

Industry Challenges: • High onboarding time, cost of change as well as rising cost • Inefficient ways to measure marketing campaign effectiveness • Lack of United Semantics to drive artificial intelligence and insights All these leading to a performance gap of drug/medical device from estimated potential success. Solution: Infosys’ commercial platform will provide “one version of truth” which would be faster to insights, adaptable to client needs, scalable across the portfolio through deep dive analytics using AWS Cloud Native and industry leading technology. • Commercia Personas : Analytics for brand specific roles which helps in brand optimization, salesforce analytics, multichannel resulting in reduced time to actionable insights • Artificial Intelligence and Machine Learning : Through industry leading AWS technologies, accelerates innovation and opens up new frontiers such as disease detection, right interventions • Integrated Data and Technology : Creates the backbone of informationtied around patient ID’sto provide dynamic and easier access to information Features of the Platform: • Domain Centric KPIs, Dashboards and Analytical Model Library • Configurable Data Quality Automation Engine and AI/ML Libraries/Dashboards • Foundation Data Model Framework, Data templates and Intelligence Grid, Entity Resolution • Supported by Leading AWS Cloud Native Analytics Technology (Amazon Redshift, Sagemaker, Amazon EMR) and Amazon Aurora Benefit to Pharmaceutical and Medical Devices Industry: • Increased sales by approximately 15%-20% • Increased Market share by approx.. 30% • Faster time to market by approximately 40%